EMA-2023-0062-V462

Type IA variation for application EMA-2023-0062. Type IA variation: Formulation Change for Respiralimab — major revision

Variation Number
EMA-2023-0062-V462
Type
Type IA
Application
EMA-2023-0062
Change
CHG-2023-0162
Status
Pending
Fee
€2,201
Submitted
2022-08-02
Approved
—
Description

Type IA variation: Formulation Change for Respiralimab — major revision